# James A. Fagin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-a-fagin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,000 |
| Field | Thyroid Cancer Diagnosis and Treatment |
| h-index | 93 |
| i10-index | 234 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5080716045 |
| ORCID iD | https://orcid.org/0000-0002-2365-2517 |
| Works | 639 |

## Researcher papers

- [Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer](https://scholariq.org/papers/association-between-braf-v600e-mutation-and-mortality-in-patients-with-papillary/)
- [Cancer therapy shapes the fitness landscape of clonal hematopoiesis](https://scholariq.org/papers/cancer-therapy-shapes-the-fitness-landscape-of-clonal-hematopoiesis/)
- [Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas](https://scholariq.org/papers/relief-of-profound-feedback-inhibition-of-mitogenic-signaling-by-raf-inhibitors/)
- [Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for <i>BRAF, PIK3CA</i> , and <i>AKT1</i>](https://scholariq.org/papers/mutational-profile-of-advanced-primary-and-metastatic-radioactive-iodine/)
- [Association Between <i>BRAF</i> V600E Mutation and Recurrence of Papillary Thyroid Cancer](https://scholariq.org/papers/association-between-i-braf-i-v600e-mutation-and-recurrence-of-papillary-thyroid/)
- [Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution](https://scholariq.org/papers/endocrine-related-adverse-events-following-ipilimumab-in-patients-with-advanced/)
- [Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation](https://scholariq.org/papers/small-molecule-mapk-inhibitors-restore-radioiodine-incorporation-in-mouse/)
- [Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i> -Mutant Thyroid Carcinomas](https://scholariq.org/papers/relief-of-feedback-inhibition-of-i-her3-i-transcription-by-raf-and-mek/)
- [Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer](https://scholariq.org/papers/genomic-and-biological-characterization-of-exon-4-kras-mutations-in-human-cancer/)

## Researcher topics

- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment-2/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Nutrition, Genetics, and Disease](https://scholariq.org/topics/nutrition-genetics-and-disease/)
- [Thyroid Disorders and Treatments](https://scholariq.org/topics/thyroid-disorders-and-treatments-2/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.